Walleye Trading
TGTX icon

Walleye Trading’s TG Therapeutics TGTX Stock Holding History

Walleye Trading’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Buy
46,600
+34,900
+298% +$1.04M ﹤0.01% 1861
2025
Q4 		$349K Sell
11,700
-10,600
-48% -$346K ﹤0.01% 3057
2025
Q3 		$806K Sell
22,300
-43,000
-66% -$1.42M ﹤0.01% 2412
2025
Q2 		$2.35M Buy
65,300
+19,000
+41% +$707K ﹤0.01% 1637
2025
Q1 		$1.83M Sell
46,300
-13,000
-22% -$437K ﹤0.01% 1697
2024
Q4 		$1.78M Buy
59,300
+32,100
+118% +$921K ﹤0.01% 1760
2024
Q3 		$636K Buy
27,200
+12,500
+85% +$273K ﹤0.01% 2372
2024
Q2 		$262K Sell
14,700
-4,600
-24% -$73.4K ﹤0.01% 2920
2024
Q1 		$294K Sell
19,300
-7,700
-29% -$123K ﹤0.01% 3196
2023
Q4 		$461K Buy
27,000
+2,600
+11% +$30.2K ﹤0.01% 3148
2023
Q3 		$204K Buy
24,400
+10,100
+71% +$141K ﹤0.01% 3586
2023
Q2 		$355K Sell
14,300
-9,500
-40% -$245K ﹤0.01% 3037
2023
Q1 		$358K Buy
23,800
+10,100
+74% +$153K ﹤0.01% 3082
2022
Q4 		$162K Sell
13,700
-48,300
-78% -$351K ﹤0.01% 3735
2022
Q3 		$367K Buy
62,000
+46,000
+288% +$302K ﹤0.01% 3176
2022
Q2 		$68K Buy
+16,000
New +$99.9K ﹤0.01% 4236
2022
Q1 		– Sell
-11,600
Closed -$220K – 5911
2021
Q4 		$220K Buy
11,600
+2,600
+29% +$67.5K ﹤0.01% 3781
2021
Q3 		$300K Buy
9,000
+4,900
+120% +$152K ﹤0.01% 3453
2021
Q2 		$159K Buy
+4,100
New +$161K ﹤0.01% 4100
2021
Q1 		– Sell
-7,500
Closed -$390K – 5290
2020
Q4 		$390K Buy
+7,500
New +$253K ﹤0.01% 2903

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Walleye Trading's TGTX Position: Q1 2026 in Review

Walleye Trading reduced its TG Therapeutics (TGTX) stake by 85% in Q1 2026, selling an estimated $928K and leaving 5,386 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

Walleye Trading first reported a position in TGTX in Q4 2019 and has held it in 16 quarters since. The position peaked at $1.09M in Q4 2025. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Walleye Trading held 5,386 shares of TG Therapeutics worth $179K as of Q1 2026.
  • Walleye Trading sold 31,155 TG Therapeutics shares in Q1 2026, an estimated $928K.
  • TG Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3175 holding.
  • Walleye Trading first reported a position in TG Therapeutics in Q4 2019 and has held it in 16 quarters since.
  • Walleye Trading's TG Therapeutics position peaked at $1.09M in Q4 2025.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.